S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
S&P 500   2,789.82 (+1.45%)
DOW   23,719.37 (+1.22%)
QQQ   200.86 (+0.14%)
AAPL   267.99 (+0.72%)
FB   175.19 (+0.52%)
MSFT   165.14 (+0.01%)
GOOGL   1,206.57 (-0.04%)
AMZN   2,042.76 (-0.01%)
CGC   14.57 (-1.75%)
NVDA   262.86 (-1.53%)
BABA   196.37 (+0.20%)
MU   46.13 (-4.47%)
GE   7.14 (-2.19%)
TSLA   573.00 (+4.40%)
AMD   48.38 (-0.84%)
T   30.73 (+2.81%)
ACB   0.88 (+2.34%)
F   5.37 (+6.76%)
NFLX   370.81 (-0.08%)
BAC   24.86 (+6.01%)
GILD   73.51 (-1.97%)
DIS   104.50 (+3.39%)
PRI   102.14 (+4.75%)
Log in

ASX:UBIUniversal Biosensors Stock Price, Forecast & News

A$0.18
-922,212.82 (-100.00 %)
(As of 04/9/2020 04:00 PM ET)
Add
Compare
Today's Range
A$0.17
Now: A$0.18
A$0.18
50-Day Range
A$0.13
MA: A$0.16
A$0.20
52-Week Range
A$0.13
Now: A$0.18
A$0.26
Volume190,478 shs
Average Volume66,890 shs
Market Capitalization$31.96 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, operates as a medical diagnostics company in Australia. It focuses on the research, development, and manufacture of in vitro diagnostic test devices for consumer and professional point-of-care use. The company uses electrochemical cell technology platform to develop point-of-care testing systems for various markets. Its products and services include prothrombin time international normalized ratio coagulation test strips; and blood glucose monitoring supplies. Universal Biosensors, Inc. has collaboration agreement with Siemens Healthcare Diagnostics Inc. to develop coagulation related products for hospital point-of-care and ambulatory care coagulation markets. The company was founded in 2001 and is based in Rowville, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.53 out of 5 stars


Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+61-3-92139000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$6.90 million
Cash FlowA$0.17 per share
Book ValueA$0.26 per share

Profitability

Miscellaneous

Employees50
Market Cap$31.96 million
Next Earnings DateN/A
OptionableNot Optionable

Receive UBI News and Ratings via Email

Sign-up to receive the latest news and ratings for UBI and its competitors with MarketBeat's FREE daily newsletter.


Universal Biosensors (ASX:UBI) Frequently Asked Questions

How were Universal Biosensors' earnings last quarter?

Universal Biosensors, Inc. (ASX:UBI) released its earnings results on Tuesday, April, 30th. The company reported ($0.01) EPS for the quarter. View Universal Biosensors' earnings history.

Has Universal Biosensors been receiving favorable news coverage?

Press coverage about UBI stock has trended very negative on Thursday, according to InfoTrie. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Universal Biosensors earned a news impact score of -3.3 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutUniversal Biosensors.

Who are some of Universal Biosensors' key competitors?

Who are Universal Biosensors' key executives?

Universal Biosensors' management team includes the following people:
  • Mr. Rick Legleiter B.S., M.B.A., Chief Exec. Officer (Age 59)
  • Mr. Salesh Balak, CFO & Company Sec. (Age 50)
  • Ms. Judy Andrews, Director of Operations & Manufacturing Engineering
  • Ms. Irene Wong, HR Director
  • Dr. Ronald Chatelier BSc. (Hons.), Ph.D., Chief Research Scientist (Age 59)

What is Universal Biosensors' stock symbol?

Universal Biosensors trades on the ASX under the ticker symbol "UBI."

What is Universal Biosensors' stock price today?

One share of UBI stock can currently be purchased for approximately A$0.18.

How big of a company is Universal Biosensors?

Universal Biosensors has a market capitalization of $31.96 million and generates $6.90 million in revenue each year. Universal Biosensors employs 50 workers across the globe. View additional information about Universal Biosensors.

What is Universal Biosensors' official website?

The official website for Universal Biosensors is http://www.universalbiosensors.com/.

How can I contact Universal Biosensors?

Universal Biosensors' mailing address is Rowville, 1 Corporate Ave, MELBOURNE, VIC 3178, Australia. The company can be reached via phone at +61-3-92139000.

This page was last updated on 4/9/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel